Results 181 to 190 of about 86,752 (290)

The Relation of Angiotensin-Converting Enzyme 2, Renin-Angiotensin-Aldosterone System Inhibitors, and Arterial Stiffness in Acute COVID-19 Emergency Department Patients—A Prospective Observational Study [PDF]

Sebastian Schnaubelt, Anna Jakobljevich, Roman Brock, Julia Oppenauer, Andrea Kornfehl, Felix Eibensteiner, Christoph Veigl, Thomas Perkmann, Helmuth Haslacher, Robert Straßl, Roman Reindl‐Schwaighofer, Oliver Schlager, Patrick Sulzgruber   +12 more
openalex   +1 more source

Angiotensin‐(1–7) Alleviates Isoproterenol‐Induced Cardiac Hypertrophy by Suppressing Autophagy and Apoptosis Through the Synergistic Action of Mas Receptor and Angiotensin II Type 2 Receptor

Acta Physiologica, Volume 242, Issue 4, April 2026.
ABSTRACT Aim The aim of this study is to determine whether Angiotensin‐(1–7) [Ang‐(1–7)] alleviates isoproterenol (ISO)–induced cardiac hypertrophy by suppressing excessive autophagy and apoptosis through coordinated Mas receptor (MasR) and angiotensin II type‐2 receptor (AT2R) signaling, and to elucidate the underlying mechanisms.
Xiaomei Wang, Fei Guo, Xiaoqian Wang, Yu Guo, Siyao Fan, Lan Hong, Honghua Jin   +6 more
wiley   +1 more source

Hypertension in obstructive sleep apnea: the hidden role of renin-angiotensin-aldosterone system dysregulation. [PDF]

Trop Med Health
Loh HH, Tay SP, Koa AJ, Yong MC, Said A, Chai CS, Malik NMA, Su AT, Tang BBC, Tan FHS, Azizan EA, Sukor N.   +11 more
europepmc   +1 more source

A Retrospective Analysis of Human Angiotensin II Receptor Blockers (ARB) Pharmacokinetics, Dosages and Cmax Values for the Experimental Modelling of Pleiotropic and Supratherapeutic Activities

Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 4, April 2026.
ABSTRACT Angiotensin II (AngII) receptor blockers (ARBs) are medications that lower systolic blood pressure (BP) by antagonizing the AngII type 1 receptor (AT1). However, ARBs have documented or suspected therapeutic properties in diseases not caused by high BP including diabetes, muscular dystrophy, chronic obstructive pulmonary diseases (COPD) and ...
Alexandria Evans, Pascal Bernatchez
wiley   +1 more source

Renin-angiotensin aldosterone system inhibitors usage among hospitalized patients with acute kidney injury: a retrospective study. [PDF]

Ann Med
Xu L, Zhou Q, Tang L, Xu D, Yang L, Zheng X.   +5 more
europepmc   +1 more source

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) III: Endogenous Inhibition of Angiotensin Converting Enzyme (ACE) Provides Protection against Cardiovascular Diseases

, 2014
Miklós Fagyas, Úri Katalin, Ivetta Mányiné Siket, Andrea Daragó, Judit Boczán, Emese Bányai, István Édes, Zoltán Papp, Attila Tóth   +8 more
openalex   +2 more sources

Causal Effects of Renin–Angiotensin–Aldosterone System Inhibition on Renal Function in Patients With Chronic Kidney Disease: A Quasi‐Experimental Study

Clinical and Translational Science, Volume 19, Issue 4, April 2026.
ABSTRACT Renin–angiotensin–aldosterone system inhibitors are widely prescribed for chronic kidney disease, but their causal effect on kidney function remains uncertain. This study investigated the impact of starting renin–angiotensin blockade on renal function in adults with kidney disease.
Tae Ryom Oh, Jiyong Park, Hong Sang Choi, Harin Rhee, Gaeun Kang   +4 more
wiley   +1 more source

Effects of SGLT-2 inhibitors on renin-angiotensin-aldosterone system and their correlation with glucose metabolism in type 2 diabetes mellitus patients with hypertension: A prospective study. [PDF]

PLoS One
Wang N, Kong J, Lu Z, Cao F, Tian E, Li J, Li S, Liu S, Yue B.   +8 more
europepmc   +1 more source

Inducible Knock-Down of the Mineralocorticoid Receptor in Mice Disturbs Regulation of the Renin-Angiotensin-Aldosterone System and Attenuates Heart Failure Induced by Pressure Overload

, 2015
Elena Montes‐Cobos, Xiao Li, Henrike J. Fischer, André Sasse, Sebastian Kügler, Michael Didié, Karl Toischer, Martin Faßnacht, Ralf Dressel, Holger M. Reichardt   +9 more
openalex   +2 more sources

Diabetic kidney disease, biomarkers, and finerenone

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2582-2593, April 2026.
Abstract Diabetic kidney disease (DKD), the leading cause of kidney failure worldwide, is associated with an increased risk of cardiovascular disease (CVD). A complex pathobiology involving hemodynamic, metabolic, and immune dysregulation promotes inflammatory and fibrotic pathways that contribute to kidney disease progression and CVD in individuals ...
Ashish Verma, Ashish Upadhyay
wiley   +1 more source